Compare GHRS & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHRS | NSP |
|---|---|---|
| Founded | 2018 | 1986 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 1.1B |
| IPO Year | 2021 | 1996 |
| Metric | GHRS | NSP |
|---|---|---|
| Price | $21.47 | $31.78 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 3 |
| Target Price | $41.38 | ★ $47.67 |
| AVG Volume (30 Days) | 255.6K | ★ 809.8K |
| Earning Date | 05-01-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 6.45% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.88 |
| Revenue | N/A | ★ $6,812,000,000.00 |
| Revenue This Year | N/A | $3.45 |
| Revenue Next Year | N/A | $6.95 |
| P/E Ratio | ★ N/A | $36.97 |
| Revenue Growth | N/A | ★ 3.51 |
| 52 Week Low | $9.52 | $18.57 |
| 52 Week High | $24.66 | $72.23 |
| Indicator | GHRS | NSP |
|---|---|---|
| Relative Strength Index (RSI) | 61.88 | 53.66 |
| Support Level | $12.29 | $31.00 |
| Resistance Level | $24.66 | $38.78 |
| Average True Range (ATR) | 1.26 | 2.34 |
| MACD | -0.02 | -0.23 |
| Stochastic Oscillator | 67.11 | 40.17 |
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.